/PRNewswire/ Chinese leading biopharmaceutical company 3SBio (01530.HK) today released its 2023 interim results. Revenue in the first half of 2023 reached.
Certain A Shares of Sunshine Guojian Pharmaceutical Co., Ltd are subject to a Lock-Up Agreement Ending on 21-JUL-2023. These A Shares will be under lockup for 1102 days starting from 14-JUL-2020 to.
The Rheumatoid Arthritis (RA) treatment market has witnessed significant growth in recent years, driven by the rising prevalence of rheumatoid arthritis
/PRNewswire/ DelveInsight s Soft Tissue Sarcoma Pipeline Insight – 2023 report provides comprehensive global coverage of available, marketed, and pipeline.